AAVLife

AAVLife

AAVLife

AAVLife's lead indication is for Friedreichs Ataxia Cardiomyopathy. Their program is based on the successful use of a genetherapy
Founded
2014
Raised
$12M
Follow us
Alexa global traffic share
15 Apr 2014
$12,000,000
Venture capital (Series A)